We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Agenus Inc is an American biotechnology company. Its main target is immuno-oncology treatments. The company's portfolio consists of therapeutic antibodies and vaccines to treat immuno-oncology illnesses: cancers, shingles, malaria, glioblastoma, and others. Agenus treatments aim, by combining multip... Agenus Inc is an American biotechnology company. Its main target is immuno-oncology treatments. The company's portfolio consists of therapeutic antibodies and vaccines to treat immuno-oncology illnesses: cancers, shingles, malaria, glioblastoma, and others. Agenus treatments aim, by combining multiple antibody platforms, to stimulate the immune system to recognize and fight cancer cells. The company has been cooperating with companies like Incyte, Merck Sharpe & Dohme, and Recepta Biopharma to achieve over a dozen antibody programs. Some of its products include Prophage, AutoSynVax, QS-21 Stimulon, and others. Show more
Agenus Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - AGEN PR Newswire NEW YORK, Oct. 28, 2024 NEW YORK, Oct. 28, 2024 /PRNewswire/...
Shareholders that lost money on Agenus Inc.(AGEN) should contact The Gross Law Firm about pending Class Action - AGEN PR Newswire NEW YORK, Oct. 17, 2024 NEW YORK, Oct. 17, 2024 /PRNewswire/...
Shareholders that lost money on Agenus Inc.(AGEN) Urged to Join Class Action - Contact The Gross Law Firm to Learn More PR Newswire NEW YORK, Oct. 14, 2024 NEW YORK, Oct. 14, 2024 /PRNewswire/...
Agenus Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before November 5, 2024 to Discuss Your Rights - AGEN PR Newswire NEW YORK, Oct. 10, 2024 NEW YORK...
Agenus Inc. Class Action: The Gross Law Firm Reminds Agenus Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 5, 2024 - AGEN PR Newswire NEW YORK, Oct. 7...
The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Agenus Inc.(AGEN) Shareholders PR Newswire NEW YORK, Sept. 30, 2024 NEW YORK, Sept. 30, 2024 /PRNewswire/ -- The...
AGEN LAWSUIT ALERT: The Gross Law Firm Notifies Agenus Inc. Investors of a Class Action Lawsuit and Upcoming Deadline PR Newswire NEW YORK, Sept. 26, 2024 NEW YORK, Sept. 26, 2024 /PRNewswire/...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.01 | 0.225225225225 | 4.44 | 4.541 | 4.3 | 220990 | 4.43382764 | CS |
4 | -1.09 | -19.6750902527 | 5.54 | 5.54 | 4.18 | 294731 | 4.60322167 | CS |
12 | -0.85 | -16.0377358491 | 5.3 | 6.53 | 4.18 | 382911 | 5.15820261 | CS |
26 | -7.66 | -63.2535094963 | 12.11 | 19.688 | 4.18 | 630341 | 9.69568016 | CS |
52 | -11.204 | -71.5727609557 | 15.654 | 19.688 | 4.18 | 5289579 | 13.4772792 | CS |
156 | -73.75 | -94.3094629156 | 78.2 | 93.8 | 4.18 | 4872465 | 32.93628283 | CS |
260 | -44.15 | -90.8436213992 | 48.6 | 135.8 | 4.18 | 4126611 | 47.49361077 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions